BIOSPAIN
The meeting will bring together 1,500 professionals, including Erik Zabala, CEO of ZABALA Innovation, who will participate in the round table on Next Generation Funds to be held on 30 September
BioSpain, a benchmark event in the international biotechnology sector, will hold its tenth edition between September 27 and October 1. The meeting will be attended by 1,500 professionals, 50 investment agents and more than 30 countries in a hybrid version brought about by the Covid-19 pandemic.
Some of the topics to be discussed at the conference will be the new healthcare challenges in the face of possible future pandemics, new genome editing techniques, how to find more funding for R&D, personalized medicine… Erik Zabala, CEO of ZABALA Innovation, will attend as a representative at the round table on Next Generation Funds on 30 September at the Palacio de Congresos de Navarra (Baluarte).
The conference is organised by the Spanish Association of Biocompanies (AseBio), in coordination with the Government of Navarra and the Society for the Development of Navarra (SODENA), in addition to the collaboration of Merck, ICEX Spain Export and Investment and the Galician Innovation Agency, GAIN.
Thanks to this meeting, Navarre will be a showcase for the talent and quality of Spanish biotech companies, where more than 3,000 ‘one-to-one’ meetings will be held to identify opportunities for collaboration and investment.
Spain is the tenth scientific power in the world and the fifth in scientific production in the European Union. It also has an extensive network of 800 hospitals, both public and private, which are supported by cutting-edge research centers. This makes the system ideal for translational medicine and the discovery of new drugs and advanced therapies.
It is a country with a consolidated biotechnology sector and an established pharmaceutical industry, which allows biotech companies to grow faster than in other countries and the pharmaceutical industry to be the leader in R&D spending in Spain.
It also has government support through loans, grants and a competitive tax incentive scheme. It also has an excellent infrastructure for innovation, with the exponential growth of science and technology parks; and a highly skilled workforce, as the percentage of workers with postgraduate studies is higher than the European average.
The cost-benefit ratio of human capital is favorable, because the cost per hour is lower than the EU average, and although the salary is lower, the attractiveness of working on scientific or biotechnology projects in Spain is high.
https://www.biospain2021.org/
News
The actions include extended deadlines in Horizon 2020 and additional funding opportunities for viral research.
Opinion
ATELIER PROJECT
Julen Ugalde
Head of European Projects at the Bilbao office
Publication
LIFE
We present the LIFE Programme's WHITE PAPER, especially useful if you are thinking of submitting your proposal to the 2022 call for proposals
To maximise the success and impact of a project, we manage the communication and dissemination activities, but we also define a social innovation strategy and tools to measure its impact.
The expertise gained working with different EU programmes over the past decades has made Zabala Innovation the best partner to manage your European project.
We provide advice to activities that encourage innovation, aimed at promoting the development of new innovative markets from the demand side, through public procurement.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.
Keeping this cookie enabled helps us to improve our website.
Please enable Strictly Necessary Cookies first so that we can save your preferences!
This website uses the following additional cookies:
(List the cookies that you are using on the website here.)
Please enable Strictly Necessary Cookies first so that we can save your preferences!